NAGE
Niagen Bioscience
NAGE
NAGE
53 hedge funds and large institutions have $16.5M invested in Niagen Bioscience in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
2% less funds holding
Funds holding: 54 → 53 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Holders
53
Holding in Top 10
–
Calls
$87K
Puts
$18K
Top Buyers
| 1 | +$660K | |
| 2 | +$170K | |
| 3 | +$62.6K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$49.2K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$47.9K |
Top Sellers
| 1 | -$433K | |
| 2 | -$151K | |
| 3 | -$136K | |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$17.6K |
| 5 |
Two Sigma Investments
New York
|
-$16.3K |